The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase II trial of efficacy and safety of entospletinib (ENTO) in patients with lymphoplasmacytoid lymphoma/Waldenstrom's macroglubulinemia (LPL/WM).
 
Sarit E. Assouline
Consulting or Advisory Role - Gilead Sciences
Research Funding - Gilead Sciences
 
Kathryn S. Kolibaba
Honoraria - TG Therapeutics
Consulting or Advisory Role - Gilead Sciences; Seagen
Research Funding - Acerta Pharma (Inst); Amgen (Inst); Celgene (Inst); Cell Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Leonard M. Klein
No Relationships to Disclose
 
Morton Coleman
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Bayer; Gilead Sciences
Speakers' Bureau - Celgene; Gilead Sciences; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst)
 
Mitchell Reed Smith
Honoraria - Genentech
Research Funding - Gilead Sciences; Kite, a Gilead company; Seagen
 
Esteban Abella-Dominicis
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Wei Ye
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Wen Shi
Employment - Gilead Sciences
Stock and Other Ownership Interests - FibroGen; Gilead Sciences
 
David Jacob Andorsky
Research Funding - ARIAD; Celgene; CTI; Gilead Sciences
 
Jeff Porter Sharman
Leadership - US Oncology
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Pharmacyclics; TG Therapeutics
Speakers' Bureau - Gilead Sciences
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
Expert Testimony - Gilead Sciences